Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.48 USD | -1.28% | +0.08% | +15.27% |
Apr. 11 | Collegium Pharmaceutical to Redeem $26.35 Million of Senior Notes | MT |
Feb. 26 | Piper Sandler Adjusts Price Target on Collegium Pharmaceutical to $39 From $37, Maintains Overweight Rating | MT |
Business Summary
Number of employees: 197
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 464 | 100.0 % | 567 | 100.0 % | +22.17% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 464 | 100.0 % | 567 | 100.0 % | +22.17% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 01-12-31 | |
Joseph Ciaffoni
CEO | Chief Executive Officer | 53 | 17-05-30 |
Colleen Tupper
DFI | Director of Finance/CFO | 48 | 21-05-23 |
Scott Sudduth
CTO | Chief Tech/Sci/R&D Officer | - | 18-01-31 |
Shirley Kuhlmann
ADM | Chief Administrative Officer | 40 | 18-03-15 |
Thomas Smith
CTO | Chief Tech/Sci/R&D Officer | 63 | 22-03-22 |
Investor Relations Contact | - | 22-12-31 | |
Kelly Clements
HRO | Human Resources Officer | - | 22-04-30 |
Scott Dreyer
PRN | Corporate Officer/Principal | 52 | 17-12-31 |
Arun Padmanabhan
SAM | Sales & Marketing | - | 17-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 14-12-31 |
Gino Santini
BRD | Director/Board Member | 66 | 12-07-23 |
John Freund
BRD | Director/Board Member | 70 | 14-01-31 |
Joseph Ciaffoni
CEO | Chief Executive Officer | 53 | 17-05-30 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 17-08-08 |
Founder | 59 | 01-12-31 | |
John A. Fallon
BRD | Director/Board Member | 76 | 16-06-12 |
Neil McFarlane
BRD | Director/Board Member | 51 | 22-04-05 |
Director/Board Member | 63 | 20-09-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 39,029,639 | 32,245,170 ( 82.62 %) | 6,323,892 ( 16.20 %) | 82.62 % |
Company contact information
Collegium Pharmaceutical, Inc.
100 Technology Center Drive Suite 300
02072, Stoughton
+781 713 3699
http://www.collegiumpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.76% | 1.18B | |
+27.92% | 672B | |
+26.94% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+7.19% | 217B | |
+5.81% | 199B | |
-8.18% | 204B | |
-8.58% | 149B |
- Stock Market
- Equities
- COLL Stock
- Company Collegium Pharmaceutical, Inc.